Epi-, Epoxy-, and C2-modified Bengamides: Synthesis and Biological Evaluation
Overview
Authors
Affiliations
With the objective of investigating the influence of structural modifications of the polyketide chain of the bengamides upon their antitumoral activities, we targeted the preparation of bengamide E analogues with modification of the stereochemistry at C-2 and at C-3, the substituent at the C-2 position, and the presence of oxirane rings. For the synthesis of these analogues, a new synthetic method for asymmetric epoxidation, developed in our laboratories, was employed utilizing the chiral sulfonium salts 22 and 23. In order to access 2-epi-bengamide E from these epoxy amides, a synthetic methodology, developed by Miyashita, allowed an oxirane-ring-opening reaction with a double inversion of the configuration. Alternatively, an aldol reaction provided access to the same analogue in a shorter and more efficient manner. Finally, biological evaluation of all of these bengamide E analogues demonstrated that the polyketide chain is essential for the antitumor activity of these natural products, not being amenable to structural or configurational modifications.
Moya-Utrera F, Cheng-Sanchez I, Fuentes-Pino I, Sanchez-Ruiz A, Sarabia F Mar Drugs. 2025; 23(2).
PMID: 39997175 PMC: 11857374. DOI: 10.3390/md23020051.
Total Synthesis of 4--Bengamide E.
Vitali Forconesi G, Basso A, Banfi L, Gugliotta D, Lambruschini C, Nola M Molecules. 2024; 29(8).
PMID: 38675534 PMC: 11052282. DOI: 10.3390/molecules29081715.
Epoxide-Based Synthetic Approaches toward Polypropionates and Related Bioactive Natural Products.
Rodriguez-Berrios R, Isbel S, Bugarin A Int J Mol Sci. 2023; 24(7).
PMID: 37047173 PMC: 10094535. DOI: 10.3390/ijms24076195.
The Development of the Bengamides as New Antibiotics against Drug-Resistant Bacteria.
Porras-Alcala C, Moya-Utrera F, Garcia-Castro M, Sanchez-Ruiz A, Lopez-Romero J, Soledad Pino-Gonzalez M Mar Drugs. 2022; 20(6).
PMID: 35736176 PMC: 9228497. DOI: 10.3390/md20060373.
Garcia-Pinel B, Porras-Alcala C, Cabeza L, Ortiz R, Prados J, Melguizo C Mar Drugs. 2020; 18(5).
PMID: 32370307 PMC: 7281506. DOI: 10.3390/md18050240.